Article Versions Notes

Tunger A, Sommer U, Wehner R, Kubasch AS, Grimm M-O, Bachmann MP, Platzbecker U, Bornhäuser M, Baretton G, Schmitz M. The Evolving Landscape of Biomarkers for Anti-PD-1 or Anti-PD-L1 Therapy. Journal of Clinical Medicine. 2019; 8(10):1534. https://doi.org/10.3390/jcm8101534

Tunger, Antje, Ulrich Sommer, Rebekka Wehner, Anne Sophie Kubasch, Marc-Oliver Grimm, Michael Philipp Bachmann, Uwe Platzbecker, Martin Bornhäuser, Gustavo Baretton, and Marc Schmitz. 2019. "The Evolving Landscape of Biomarkers for Anti-PD-1 or Anti-PD-L1 Therapy" Journal of Clinical Medicine 8, no. 10: 1534. https://doi.org/10.3390/jcm8101534

Tunger, A., Sommer, U., Wehner, R., Kubasch, A. S., Grimm, M.-O., Bachmann, M. P., Platzbecker, U., Bornhäuser, M., Baretton, G., & Schmitz, M. (2019). The Evolving Landscape of Biomarkers for Anti-PD-1 or Anti-PD-L1 Therapy. Journal of Clinical Medicine, 8(10), 1534. https://doi.org/10.3390/jcm8101534